• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

野葛淀粉通过调节肠道微生物群缓解高脂高胆固醇饮食诱导的非酒精性脂肪肝。

Pueraria lobata starch regulates gut microbiota and alleviates high-fat high-cholesterol diet induced non-alcoholic fatty liver disease in mice.

机构信息

Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China; Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China.

Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China; Cell Therapy & Cell Drugs of Luzhou Key Laboratory, Luzhou, Sichuan, China; South Sichuan Institute of Translational Medicine, Luzhou, Sichuan, China.

出版信息

Food Res Int. 2022 Jul;157:111401. doi: 10.1016/j.foodres.2022.111401. Epub 2022 May 26.

DOI:10.1016/j.foodres.2022.111401
PMID:35761655
Abstract

The dried roots of Pueraria lobata (Willd.) Ohwi as an edible medicinal herb are enriched with starch. However, the structure, physiology, and biological bioactivity of P. lobata starch (PLS) has not yet been fully investigated. This study showed that PLS consisted of mixed population of granules with polyhedral or spherical surface. The apparent content of resistant starch was 23.14%, and the molecular weight was 1.93 × 10 Da. PLS showed a branching degree and an average polymerization rate of 2.06% and 20.74%, respectively, with fairly high proportion of B1 short chains. The solubility and swelling power of PLS were 38.51% and 28.10 g/g, respectively, showing high hot stability of the viscosity. In vitro fermentation of PLS resulted in specifically altered composition of gut microbiota and increased production of SCFAs, showing a potential prebiotic effect. Moreover, PLS remarkably alleviated inflammation, hepatic steatosis and dyslipidemia in mice with high-fat high-cholesterol diet induced non-alcoholic fatty liver disease (NAFLD). The protective effect of PLS was associated with amelioration of NAFLD-associated gut dysbiosis through specifically increasing the abundance of Lactobacillus, Bifidobacterium and Turicibacter, and decreasing Desulfovibrio. The results would support the use of PLS as a functional prebiotic for protecting against NAFLD.

摘要

野葛的干根(野葛)作为一种可食用的药用植物,富含淀粉。然而,野葛淀粉(PLS)的结构、生理学和生物生物活性尚未得到充分研究。本研究表明,PLS 由具有多面或球形表面的颗粒的混合群体组成。抗性淀粉的表观含量为 23.14%,分子量为 1.93×10 Da。PLS 的分支度和平均聚合度分别为 2.06%和 20.74%,具有相当高比例的 B1 短链。PLS 的溶解度和溶胀能力分别为 38.51%和 28.10 g/g,表现出较高的热稳定性。PLS 的体外发酵导致肠道微生物群组成发生特定改变,并增加了 SCFAs 的产生,显示出潜在的益生元作用。此外,PLS 可显著减轻高脂肪高胆固醇饮食诱导的非酒精性脂肪性肝病(NAFLD)小鼠的炎症、肝脂肪变性和血脂异常。PLS 的保护作用与改善与 NAFLD 相关的肠道菌群失调有关,具体表现为增加乳酸杆菌、双歧杆菌和瘤胃球菌的丰度,减少脱硫弧菌的丰度。这些结果将支持将 PLS 用作预防 NAFLD 的功能性益生元。

相似文献

1
Pueraria lobata starch regulates gut microbiota and alleviates high-fat high-cholesterol diet induced non-alcoholic fatty liver disease in mice.野葛淀粉通过调节肠道微生物群缓解高脂高胆固醇饮食诱导的非酒精性脂肪肝。
Food Res Int. 2022 Jul;157:111401. doi: 10.1016/j.foodres.2022.111401. Epub 2022 May 26.
2
Starch from Pueraria lobata and the amylose fraction alleviates dextran sodium sulfate induced colitis in mice.葛根淀粉及其直链淀粉部分可减轻葡聚糖硫酸钠诱导的小鼠结肠炎。
Carbohydr Polym. 2023 Feb 15;302:120329. doi: 10.1016/j.carbpol.2022.120329. Epub 2022 Nov 11.
3
Probiotic-fermented Pueraria lobata (Willd.) Ohwi alleviates alcoholic liver injury by enhancing antioxidant defense and modulating gut microbiota.益生菌发酵葛根(Willd.)Ohwi 通过增强抗氧化防御和调节肠道微生物群来缓解酒精性肝损伤。
J Sci Food Agric. 2022 Dec;102(15):6877-6888. doi: 10.1002/jsfa.12049. Epub 2022 Jun 22.
4
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites.膳食胆固醇通过调节肠道微生物群和代谢物驱动脂肪肝相关肝癌的发生。
Gut. 2021 Apr;70(4):761-774. doi: 10.1136/gutjnl-2019-319664. Epub 2020 Jul 21.
5
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.咖啡通过调节肠-肝轴途径预防高脂饮食诱导的脂肪肝疾病。
J Nutr Sci. 2019 Apr 22;8:e15. doi: 10.1017/jns.2019.10. eCollection 2019.
6
Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation.植物乳杆菌 NA136 通过调节肠道微生物群、改善肠道屏障完整性和减轻炎症来改善非酒精性脂肪性肝病。
Appl Microbiol Biotechnol. 2020 Jun;104(12):5273-5282. doi: 10.1007/s00253-020-10633-9. Epub 2020 Apr 26.
7
Spinach consumption ameliorates the gut microbiota and dislipaemia in rats with diet-induced non-alcoholic fatty liver disease (NAFLD).食用菠菜可改善饮食诱导的非酒精性脂肪肝(NAFLD)大鼠的肠道微生物群和脂血症。
Food Funct. 2019 Apr 17;10(4):2148-2160. doi: 10.1039/c8fo01630e.
8
Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice.肠道微生物群移植、槲皮素与高脂饮食之间的功能相互作用决定无菌小鼠非酒精性脂肪性肝病的发生。
Mol Nutr Food Res. 2019 Apr;63(8):e1800930. doi: 10.1002/mnfr.201800930. Epub 2019 Feb 4.
9
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.
10
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.

引用本文的文献

1
Unveiling the power of : a comprehensive exploration of its medicinal and edible potentials.揭示:对其药用和食用潜力的全面探索。 (原句中“Unveiling the power of :”这里冒号前缺少具体内容,翻译只能根据现有信息尽量贴近原意)
Front Pharmacol. 2025 Jul 10;16:1578472. doi: 10.3389/fphar.2025.1578472. eCollection 2025.
2
Gut microbiota modulation by Traditional Chinese Medicine: a translational strategy for metabolic dysfunction-associated steatotic liver disease.中药对肠道微生物群的调节作用:代谢功能障碍相关脂肪性肝病的转化策略
Front Pharmacol. 2025 Jun 10;16:1600439. doi: 10.3389/fphar.2025.1600439. eCollection 2025.
3
Puerarin Targets HIF-1α to Modulate Hypoxia-Related Sphingolipid Metabolism in Diabetic Hepatopathy via the SPTLC2/Ceramide Pathway.
葛根素通过SPTLC2/神经酰胺途径靶向缺氧诱导因子-1α调节糖尿病肝病中与缺氧相关的鞘脂代谢。
Pharmaceuticals (Basel). 2025 Mar 12;18(3):398. doi: 10.3390/ph18030398.
4
Modification of Structure, Pasting, and In Vitro Digestion Properties of Glutinous Rice Starch by Different Lactic Acid Bacteria Fermentation.不同乳酸菌发酵对糯米淀粉结构、黏附性及体外消化特性的影响
Foods. 2025 Jan 23;14(3):367. doi: 10.3390/foods14030367.
5
Gegen-Sangshen oral liquid and its active fractions mitigate alcoholic liver disease in mice through repairing intestinal epithelial injury and regulating gut microbiota.Gegen-桑椹口服液及其活性成分通过修复肠道上皮损伤和调节肠道微生物群来减轻小鼠酒精性肝病。
Chin Med. 2024 Dec 23;19(1):175. doi: 10.1186/s13020-024-01049-y.
6
A Scoping Review on Hepatoprotective Mechanism of Herbal Preparations through Gut Microbiota Modulation.通过调节肠道菌群对草药制剂肝脏保护机制的范围综述
Curr Issues Mol Biol. 2024 Oct 16;46(10):11460-11502. doi: 10.3390/cimb46100682.
7
- Complex Alleviates Alcoholic Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation: A Transcriptome and Gut Microbiota Analysis.复合物通过调节脂质代谢和抑制炎症减轻酒精性肝病:一项转录组和肠道微生物群分析
Foods. 2024 Aug 1;13(15):2431. doi: 10.3390/foods13152431.
8
Herbal medicines in Alzheimer's disease and the involvement of gut microbiota.用于治疗阿尔茨海默病的草药及肠道微生物群的作用
Front Pharmacol. 2024 Jul 16;15:1416502. doi: 10.3389/fphar.2024.1416502. eCollection 2024.
9
Fingerprint profiling for quality evaluation and the related biological activity analysis of polysaccharides from Liuweizhiji Gegen-Sangshen beverage.六味枳椇葛参饮料多糖的指纹图谱分析及其质量评价与相关生物活性分析
Front Nutr. 2024 Jul 8;11:1431518. doi: 10.3389/fnut.2024.1431518. eCollection 2024.
10
Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease.间充质基质细胞:炎症性肠病的新一代治疗方法
J Inflamm Res. 2024 May 22;17:3307-3334. doi: 10.2147/JIR.S458103. eCollection 2024.